Finished drug import value in South Korea 2015, by efficacy group

Published by Statista Research Department, Dec 19, 2022
This statistic displays the value of finished drugs imported into South Korea in 2015, by efficacy group. During the measured time period, South Korea imported anti-tumor drugs the most, amounting to around 454 million U.S. dollars.

Value of finished drugs imported into South Korea in 2015, by efficacy group (in million U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

July 2017

Region

South Korea

Survey time period

2015

Special properties

Based on most recent statistics available as of 2016

Supplementary notes

Figures have been rounded.
The information was acquired via data partnership with KOTRA.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in South Korea "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Pharmaceutical industry in South Korea

Overview

5

Production and distribution

6

International trade

6

Key players

6

OTC pharmaceuticals

6

Further related statistics

13

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in Thailand
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu